220 related articles for article (PubMed ID: 11992291)
21. The role of bacterial virulence and host factors in patients with Escherichia coli bacteremia who have acute cholangitis or upper urinary tract infection.
Wang MC; Tseng CC; Chen CY; Wu JJ; Huang JJ
Clin Infect Dis; 2002 Nov; 35(10):1161-6. PubMed ID: 12410475
[TBL] [Abstract][Full Text] [Related]
22. The presence of the virulence island containing the usp gene in uropathogenic Escherichia coli is associated with urinary tract infection in an experimental mouse model.
Yamamoto S; Nakano M; Terai A; Yuri K; Nakata K; Nair GB; Kurazono H; Ogawa O
J Urol; 2001 Apr; 165(4):1347-51. PubMed ID: 11257714
[TBL] [Abstract][Full Text] [Related]
23. Urinary tract infections in renal transplant recipients: virulence traits of uropathogenic Escherichia coli.
Merçon M; Regua-Mangia AH; Teixeira LM; Irino K; Tuboi SH; Goncalves RT; Santoro-Lopes G
Transplant Proc; 2010 Mar; 42(2):483-5. PubMed ID: 20304171
[TBL] [Abstract][Full Text] [Related]
24. Virulence determinants, phylogenetic groups and fluoroquinolone resistance in Escherichia coli isolated from cystitis and pyelonephritis.
Ferjani S; Saidani M; Ennigrou S; Hsairi M; Ben Redjeb S
Pathol Biol (Paris); 2012 Oct; 60(5):270-4. PubMed ID: 21872408
[TBL] [Abstract][Full Text] [Related]
25. Identification of DNA sequences from a second pathogenicity island of uropathogenic Escherichia coli CFT073: probes specific for uropathogenic populations.
Rasko DA; Phillips JA; Li X; Mobley HL
J Infect Dis; 2001 Oct; 184(8):1041-9. PubMed ID: 11574920
[TBL] [Abstract][Full Text] [Related]
26. Temporal changes in the prevalence of community-acquired antimicrobial-resistant urinary tract infection affected by Escherichia coli clonal group composition.
Smith SP; Manges AR; Riley LW
Clin Infect Dis; 2008 Mar; 46(5):689-95. PubMed ID: 18230040
[TBL] [Abstract][Full Text] [Related]
27. Genetic background of Escherichia coli isolates from patients with spontaneous bacterial peritonitis: relationship with host factors and prognosis.
Bert F; Panhard X; Johnson J; Lecuyer H; Moreau R; Le Grand J; Johnston B; Sinègre M; Valla D; Nicolas-Chanoine MH
Clin Microbiol Infect; 2008 Nov; 14(11):1034-40. PubMed ID: 19040475
[TBL] [Abstract][Full Text] [Related]
28. Virulence characteristics of Escherichia coli in acute bacterial prostatitis.
Mitsumori K; Terai A; Yamamoto S; Ishitoya S; Yoshida O
J Infect Dis; 1999 Oct; 180(4):1378-81. PubMed ID: 10479177
[TBL] [Abstract][Full Text] [Related]
29. Comparative study of Escherichia coli virulence determinants in strains causing urinary tract bacteremia versus strains causing pyelonephritis and other sources of bacteremia.
Moreno E; Planells I; Prats G; Planes AM; Moreno G; Andreu A
Diagn Microbiol Infect Dis; 2005 Oct; 53(2):93-9. PubMed ID: 16168618
[TBL] [Abstract][Full Text] [Related]
30. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
Arslan H; Azap OK; Ergönül O; Timurkaynak F;
J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
[TBL] [Abstract][Full Text] [Related]
31. Implication of biofilm formation in the persistence of urinary tract infection caused by uropathogenic Escherichia coli.
Soto SM; Smithson A; Horcajada JP; Martinez JA; Mensa JP; Vila J
Clin Microbiol Infect; 2006 Oct; 12(10):1034-6. PubMed ID: 16961644
[TBL] [Abstract][Full Text] [Related]
32. A prospective, longitudinal study of the behavior of serologically classified isolates of Escherichia coli in women with recurrent urinary tract infections.
Vosti KL
J Infect; 2007 Jul; 55(1):8-18. PubMed ID: 17331583
[TBL] [Abstract][Full Text] [Related]
33. Clonal groups and the spread of resistance to trimethoprim-sulfamethoxazole in uropathogenic Escherichia coli.
France AM; Kugeler KM; Freeman A; Zalewski CA; Blahna M; Zhang L; Marrs CF; Foxman B
Clin Infect Dis; 2005 Apr; 40(8):1101-7. PubMed ID: 15791508
[TBL] [Abstract][Full Text] [Related]
34. Mutator phenotype confers advantage in Escherichia coli chronic urinary tract infection pathogenesis.
Labat F; Pradillon O; Garry L; Peuchmaur M; Fantin B; Denamur E
FEMS Immunol Med Microbiol; 2005 Jun; 44(3):317-21. PubMed ID: 15907455
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of Escherichia coli among samples collected from the genital tract in pregnant and nonpregnant women: relationship with virulence.
Guiral E; Bosch J; Vila J; Soto SM
FEMS Microbiol Lett; 2011 Jan; 314(2):170-3. PubMed ID: 21133987
[TBL] [Abstract][Full Text] [Related]
36. Autotransporter-encoding sequences are phylogenetically distributed among Escherichia coli clinical isolates and reference strains.
Restieri C; Garriss G; Locas MC; Dozois CM
Appl Environ Microbiol; 2007 Mar; 73(5):1553-62. PubMed ID: 17220264
[TBL] [Abstract][Full Text] [Related]
37. Detection of virulence factors of Escherichia coli from children by multiplex polymerase chain reaction.
Arisoy M; Aysev D; Ekim M; Ozel D; Köse SK; Ozsoy ED; Akar N
Int J Clin Pract; 2006 Feb; 60(2):170-3. PubMed ID: 16451289
[TBL] [Abstract][Full Text] [Related]
38. Identification of urovirulence traits in Escherichia coli by comparison of urinary and rectal E. coli isolates from dogs with urinary tract infection.
Johnson JR; Kaster N; Kuskowski MA; Ling GV
J Clin Microbiol; 2003 Jan; 41(1):337-45. PubMed ID: 12517870
[TBL] [Abstract][Full Text] [Related]
39. Detection of virulence factors in alpha-haemolytic Escherichia coli strains isolated from various clinical materials.
Birosová E; Siegfried L; Kmet'ová M; Makara A; Ostró A; Gresová A; Urdzík P; Liptáková A; Molokácová M; Bártl R; Valanský L
Clin Microbiol Infect; 2004 Jun; 10(6):569-73. PubMed ID: 15191387
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of virulence factors and antimicrobial resistance of uropathogenic Escherichia coli in Jiangsu province (China).
Zhao L; Chen X; Zhu X; Yang W; Dong L; Xu X; Gao S; Liu X
Urology; 2009 Sep; 74(3):702-7. PubMed ID: 19362346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
